Structures by: Aziz S.
Total: 8
Ethyl 2-(1-benzyl-4-(4-methoxyphenyl)-1H-1,2,3-triazol-5-yl)-2-oxoacetate
C20H19N3O4
CrystEngComm (2020)
a=8.2922(6)Å b=9.4246(7)Å c=12.9343(10)Å
α=111.004(2)° β=99.018(3)° γ=97.623(2)°
Ethyl 2-(1-benzyl-4-(4-flourophenyl)-1H-1,2,3-triazol-5-yl)-2-oxoacetate
C19H16FN3O3
CrystEngComm (2020)
a=28.5939(14)Å b=7.5267(4)Å c=19.3890(8)Å
α=90° β=121.9640(10)° γ=90°
Ethyl 2-(1-benzyl-4-(4-chlorophenyl)-1H-1,2,3-triazol-5-yl)-2-oxoacetate
C20H18ClN3O3
CrystEngComm (2020)
a=8.3157(6)Å b=9.5082(8)Å c=13.1245(10)Å
α=68.898(4)° β=86.538(4)° γ=85.332(4)°
Ethyl 2-(1-(4-methylbenzyl)-4-phenyl-1H-1,2,3-triazol-5-yl)-2-oxoacetate
C20H19N3O3
CrystEngComm (2020)
a=8.2517(3)Å b=17.9945(9)Å c=12.2748(6)Å
α=90° β=99.877(2)° γ=90°
Ethyl 2-(benzoyloxy)benzoate
C16H14O4
Acta Crystallographica Section E (2007) 63, 2 o744-o745
a=7.2123(12)Å b=10.4116(17)Å c=18.331(3)Å
α=90.00° β=98.259(4)° γ=90.00°
Ethyl 2-({5-[2-(benzoylamino)phenyl]-1,3,4-oxadiazol-2-yl}sulfanyl)acetate
C19H17N3O4S
Acta Crystallographica Section E (2007) 63, 2 o1021-o1022
a=16.810(3)Å b=5.0834(9)Å c=21.274(4)Å
α=90.00° β=90.00° γ=90.00°
3-(1<i>H</i>-Indol-3-yl)-2-(2-nitrobenzenesulfonamido)propanoic acid
C17H15N3O6S
Acta Crystallographica Section E (2012) 68, 7 o2019
a=9.6818(5)Å b=9.6818(5)Å c=44.017(3)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-[1-(3-methylbutyl)-4-phenyl-1<i>H</i>-1,2,3-triazol-5-yl]-2-oxoacetate
C17H21N3O3
Acta Crystallographica Section E (2013) 69, 12 o1768
a=8.1710(8)Å b=10.0684(9)Å c=10.6066(10)Å
α=98.331(3)° β=94.220(3)° γ=95.367(3)°